Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Thromboinflammatory effects of RBC microvesicles

Evi X. Stavrou

Blood (2020) 135 (10): 708–709.

https://doi.org/10.1182/blood.2020004985

Published: 2020

Journal Articles

Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX

Mayken Visser, Rene van Oerle, Hugo ten Cate, MD PhD, Volker Laux, PhD, Stefan Heitmeier, PhD, Henri M.H. Spronk, PhD

Blood (2019) 134 (Supplement_1): 1106.

https://doi.org/10.1182/blood-2019-131738

Published: 2019

Journal Articles

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Steven de Maat, Wariya Sanrattana, Reiner K. Mailer, Naomi M. J. Parr, Martin Hessing, Robert M. Koetsier, Joost C. M. Meijers, Gerard Pasterkamp, Thomas Renné, Coen Maas

Blood (2019) 134 (19): 1658–1669.

https://doi.org/10.1182/blood.2019000481

Published: 2019

Includes: Supplemental data

Journal Articles

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke

Fabrício Simão, Tuna Ustunkaya, Allen C. Clermont, Edward P. Feener

Blood (2017) 129 (16): 2280–2290.

https://doi.org/10.1182/blood-2016-09-740670

Published: 2017

Includes: Supplemental data

Journal Articles

PolyP’s many faces

Alvin H. Schmaier

Blood (2016) 128 (13): 1669–1670.

https://doi.org/10.1182/blood-2016-07-724971

Published: 2016

Journal Articles

High Prevalence of Marginal ZONE Lymphoma Among Patients with Acquired C1- Inhibtor Deficiency

Roberto Castelli, Prof, Davide Rossi, MD PhD, Arquati Massimo, Suffritti Chiara, Andrea Zanichelli, Wu Maddalena, Cicardi Marco, Prof

Blood (2015) 126 (23): 1444.

https://doi.org/10.1182/blood.V126.23.1444.1444

Published: 2015

Journal Articles

Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody

Blood (2015) 126 (23): 2268.

https://doi.org/10.1182/blood.V126.23.2268.2268

Published: 2015

Journal Articles

The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis

Katrin F. Nickel, Göran Ronquist, Florian Langer, Linda Labberton, Tobias A. Fuchs, Carsten Bokemeyer, Guido Sauter, Markus Graefen, Nigel Mackman, Evi X. Stavrou, Gunnar Ronquist, Thomas Renné

Blood (2015) 126 (11): 1379–1389.

https://doi.org/10.1182/blood-2015-01-622811

Published: 2015

Includes: Supplemental data

Journal Articles

The vascular side of plasma kallikrein

Thomas Renné

Blood (2015) 125 (4): 589–590.

https://doi.org/10.1182/blood-2014-11-609016

Published: 2015

Journal Articles

Discovery of a Novel, Potent, Selective and Injectable Small Molecule Inhibitor of Blood Coagulation Factor XIa, ONO-8610539: in Vitro and in Vivo Pharmacological Profiles

Masashi Gohda, PhD, Masaru Sakai, Kenji Tanaka, Tetsuya Hagio, PhD, Keizo Suzuki, Sho Koyama, Takehiro Ono, Ai Hashimoto, Hidekazu Matsuya, Yasushi Hirota, PhD, Takashi Kondo, PhD, Taihei Nishiyama, PhD, Akira Imagawa, Kazuhito Kawabata, PhD

Blood (2014) 124 (21): 1542.

https://doi.org/10.1182/blood.V124.21.1542.1542

Published: 2014

Journal Articles

A Biomarker Assay For The Detection Of Contact System Activation

Ryan R Faucette, Marco Cicardi, MD, Chiara Suffritti, PhD, Jon A Kenniston, Daniel J Sexton, Burt Adelman

Blood (2013) 122 (21): 2347.

https://doi.org/10.1182/blood.V122.21.2347.2347

Published: 2013

Journal Articles

Thrombosis Protection In Klkb1 -/- (Prekallikrein KO) Mice Is Mediated By Increased Renal Mas Receptor, Plasma Prostacyclin, and Aortic Sirt1

Chao Fang, Evi Stavrou, MD, Yunmei Wang, PhD, Nadja Grobe, PhD, Daniel I. Simon, MD, Alvin H. Schmaier, MD

Blood (2013) 122 (21): 195.

https://doi.org/10.1182/blood.V122.21.195.195

Published: 2013

Journal Articles

Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor

Daniel J Sexton, Jon A Kenniston, Ryan R Faucette, Andrew E Nixon, Chris TenHoor, Yung Chyung, Burt Adelman

Blood (2013) 122 (21): 1066.

https://doi.org/10.1182/blood.V122.21.1066.1066

Published: 2013

Journal Articles

Induction of Endothelial Cell Apoptosis by Cleaved High Molecular Weight Kininogen Is Mediated Through a Lck and p53-Dependent Pathway

Venkaiah Betapudi, Ph.D., Keith R. McCrae, MD

Blood (2012) 120 (21): 3305.

https://doi.org/10.1182/blood.V120.21.3305.3305

Published: 2012

Journal Articles

Kininogen Deficiency Protects From Ischemic Neurodegeneration in Mice by Reducing Thrombosis, Blood-Brain-Barrier Damage and Inflammation

Friederike Langhauser, Eva Gob, Peter Kraft, Christian Geis, Joachim Schmitt, Marc Brede, Kirsten Göbel, Xavier Helluy, Mirko Pham, Martin Bendszus, Peter Jakob, Guido Stoll, Sven G Meuth, Bernhard Nieswandt, Keith R. McCrae, MD, Christoph Kleinschnitz

Blood (2012) 120 (21): 104.

https://doi.org/10.1182/blood.V120.21.104.104

Published: 2012

Journal Articles

The Kinin-Kallikre System in Chronic Lymphocytic Leukemia - A Potential Target for Therapy?

Elena Kashuba, PhD student, James R Bailey, MA, MBBS, MRCP, Laura R Sadofsky, PhD, Samantha Drennan Drennan, PhD student HYMS, Paula Johnson, David Allsup, Lynn Cawkwell, PhD

Blood (2012) 120 (21): 3904.

https://doi.org/10.1182/blood.V120.21.3904.3904

Published: 2012

Journal Articles

Analysis of Changes in Endothelial Cell Protein Expression and Phosphorylation Induced by Cleaved High Molecular Weight Kininogen

Venkaiah Betapudi, Ph.D., Keith R. McCrae, MD

Blood (2012) 120 (21): 5195.

https://doi.org/10.1182/blood.V120.21.5195.5195

Published: 2012

Journal Articles

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Fabrizio Foieni, MD, Andrea Zanichelli, MD, Anna Coerezza, MD, Roberto Castelli, MD, Lorena Maggioni, PhD, Chiara Suffritti, PhD, Erika Bonanni, Augusto B. Federici, MD, Marco Cicardi, MD

Blood (2011) 118 (21): 1596.

https://doi.org/10.1182/blood.V118.21.1596.1596

Published: 2011

Journal Articles

Antifibrinolytic Efficacy of Truncated L17R Mutant of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 (TFPI-2): Comparison with Lysine Analogues

Madhu S Bajaj, Yogesh Kumar, Godwin I Ogueli, Kanagasabai Vadivel, Amy E Schmidt, Nalaka Rannulu, Joseph Loo, S. Paul Bajaj

Blood (2011) 118 (21): 855.

https://doi.org/10.1182/blood.V118.21.855.855

Published: 2011

NARROW

Thromboinflammatory effects of RBC microvesicles

Plasma Kallikrein Contributes to Ellagic Acid-Induced Coagulation in the Absence of FXI By Activating Factor IX

Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke

PolyP’s many faces

High Prevalence of Marginal ZONE Lymphoma Among Patients with Acquired C1- Inhibtor Deficiency

Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody

The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis

The vascular side of plasma kallikrein

Discovery of a Novel, Potent, Selective and Injectable Small Molecule Inhibitor of Blood Coagulation Factor XIa, ONO-8610539: in Vitro and in Vivo Pharmacological Profiles

A Biomarker Assay For The Detection Of Contact System Activation

Thrombosis Protection In Klkb1 -/- (Prekallikrein KO) Mice Is Mediated By Increased Renal Mas Receptor, Plasma Prostacyclin, and Aortic Sirt1

Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor

Discovery and Characterization Of a Highly Specific Antibody Inhibitor Of Plasma Kallikrein

Induction of Endothelial Cell Apoptosis by Cleaved High Molecular Weight Kininogen Is Mediated Through a Lck and p53-Dependent Pathway

Kininogen Deficiency Protects From Ischemic Neurodegeneration in Mice by Reducing Thrombosis, Blood-Brain-Barrier Damage and Inflammation

The Kinin-Kallikre System in Chronic Lymphocytic Leukemia - A Potential Target for Therapy?

Analysis of Changes in Endothelial Cell Protein Expression and Phosphorylation Induced by Cleaved High Molecular Weight Kininogen

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Antifibrinolytic Efficacy of Truncated L17R Mutant of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 (TFPI-2): Comparison with Lysine Analogues

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only